running because it has 3-4 million in rebates coming after July 1st and with 5 million in the bank already the EV is 8 million while AGN which is combined with a thrombotic to work and not a unique drug like NYR was a 70 million market cap in the same position back in 2021 before GLP and before phase 1. Looking at a testing all time highs in the period ahead
running because it has 3-4 million in rebates coming after July...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $9.839M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.2¢ | $6.978K | 131.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2029207 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| NYR (ASX) Chart |